Loading
IARC estimates 8,919 new cancer cases and 4,734 cancer deaths in Nicaragua in 2024; the commonest new cancers are breast, prostate and colorectum. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 1,534 | 44.7 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 823 | 37.5 | Prostate cancer |
| Colorectum | 652 | 10.8 | Colorectal cancer |
| Cervix uteri | 621 | 18.1 | Cervical cancer |
| Liver and intrahepatic bile ducts | 614 | 10.7 | Hepatocellular carcinoma |
| Stomach | 585 | 9.7 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 482 | 7.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Non-Hodgkin lymphoma | 351 | 5.6 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Trachea, bronchus and lung | 323 | 5.5 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Thyroid | 309 | 5.0 | Thyroid cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 568 | 9.9 | Hepatocellular carcinoma |
| Stomach | 460 | 7.9 | Gastric & gastro-oesophageal junction cancer |
| Breast | 415 | 12.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 378 | 17.9 | Prostate cancer |
| Cervix uteri | 364 | 10.8 | Cervical cancer |
| Colorectum | 362 | 6.2 | Colorectal cancer |
| Leukaemia | 295 | 4.5 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Trachea, bronchus and lung | 293 | 5.1 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Non-Hodgkin lymphoma | 180 | 3.0 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Pancreas | 176 | 3.1 | Pancreatic ductal adenocarcinoma |
No trial record in OnCo lists a site in Nicaragua. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Nicaragua.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Nicaragua is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Nicaragua is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.